Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bleeding Risk Guided VTE Prophylaxis Strategy for Hospitalized Patients With Lung Cancer: Rationale and Design for a Multicenter, Adjudicator-blinded, Parallel, Randomized Clinical Trial in China

NCT04158973 is registered in ClinicalTrials.gov with China-Japan Friendship Hospital as lead sponsor.

NCT NCT04158973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04158973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bleeding Risk Guided VTE Prophylaxis Strategy for Hospitalized Patients With Lung Cancer: Rationale and Design for a Multicenter, Adjudicator-blinded, Parallel, Randomized Clinical Trial in China
Lead sponsor
China-Japan Friendship Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
December 1, 2021
Completion date
December 31, 2022
Enrollment
3,200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

deep venous thrombosis, pulmonary embolism, venous thromboembolic disease